Blog

Treating IBS-C Beyond Laxatives: New Insights from Pathophysiology and Meal Timing A 2026 review article by Mohamed et al

Pathophysiology-Driven IBS-C Management: New Insights on Natural Products and Timing Irritable bowel syndrome with constipation affects an estimated 5% …

Introduction Irritable bowel syndrome with constipation (IBS-C) is more than just infrequent bowel movements

Beyond the Laxative: A Pathophysiology-Driven Approach to IBS-C Management Irritable bowel syndrome with constipation (IBS-C) is more than slow transit

IBS-C Constipation Treatment Management: Pathophysiology and Natural Interventions Irritable bowel syndrome with constipation (IBS-C) remains a complex …

Evidence-Based IBS-C Management: Moving Beyond Symptom Relief Irritable Bowel Syndrome with Constipation (IBS-C) is characterized by abdominal pain and …

An Evidence-Based Approach to Managing IBS-C Irritable bowel syndrome with constipation affects approximately one in every twenty adults globally, makin…

IBS-C Constipation Treatment: A Pathophysiology-Driven Approach For individuals with Irritable Bowel Syndrome with constipation (IBS-C), finding consist…

IBS-C Constipation Treatment: New Evidence for a Pathophysiology-Driven Approach Irritable bowel syndrome with constipation affects millions, and its co…

Introduction A 2026 review published by researchers at Heliopolis and Cairo Universities notes that the established, multi-factorial nature of irritable…

Pathophysiology-Driven Natural Management for IBS-C Constipation Irritable bowel syndrome with constipation (IBS-C) is more than just an occasional slow…

Introduction Irritable Bowel Syndrome with constipation (IBS-C) is a complex disorder of gut-brain interaction where abdominal pain is paired with infre…